Newsroom
View news releases and announcements distributed by EZ Newswire, the trusted source for business news.
Lifemotion System Launches in Europe with First Clinical Cases in Germany and Spain
In a landmark case for lung transplantation, University Hospital of Hannover successfully treated two patients using the Lifemotion System, representing the first clinical applications outside the People's Republic of China.
Meanwhile, in Spain, the Lifemotion System demonstrated its full transport capabilities during an inter-hospital patient retrieval, operating entirely on battery power — including motor, pump, and oxygenator. This case highlighted the system’s exceptional mobility and reliability in critical-care transport, reinforcing its role as a game-changing solution in extracorporeal life support.
The Lifemotion ECMO system is CE approved for extended 14-day use, including the approval of its individual components as standalone devices, setting a new benchmark for sustained critical care support.
At both centers, clinicians praised the system’s innovative pump design, low pressure drop performance of the oxygenator, and intuitive, easy-to-use interface.
"The Lifemotion System offers a new level of flexibility and reliability in ECLS. Its compact design and battery-powered operation proved especially valuable during patient transport — with great potential for ICU, retrieval, and emergency use," said Michael van Driel, Vice President of International Business Development at CBM Lifemotion S.r.l.
To showcase the initial clinical experiences with the system, CBM Lifemotion hosted a highly successful Lunch Symposium at EuroELSO 2025 in Milan on Thursday, April 24. The event brought together internationally renowned clinical experts and leaders in extracorporeal support.
The panel, chaired by Prof. Heidi Dalton (ECMO specialist and pediatric intensivist, Scottsdale, USA), Prof. Roberto Lorusso (Professor of Cardiac Surgery and Extracorporeal Life Support, and ECLS researcher, Maastricht, The Netherlands), and Prof. Gregory J. Schears (ECMO specialist and anesthesiologist, Rochester, USA), explored the first European applications of the Lifemotion System. They also discussed its expanding clinical potential across Europe and worldwide, highlighting its role in advancing the future of extracorporeal life support.
The Lunch Symposium featured an engaging roundtable discussion with key contributions from:
- PD Dr. Bettina Wiegmann (University Hospital of Hannover Medical School,Germany) — presenting the First Clinical Experience with the CBM Lifemotion System in Europe
- Prof. Simon Sin (Queen Mary Hospital, Hong Kong) — speaking on The Importance of Training and Education in ECLS/ECMO
- Dr. Hua Zhong Zhang (Nanjing Medical University, China) — sharing insights into Practical Experience of ECPR in China
About CBM Lifemotion
CBM Lifemotion® specializes in advanced Extracorporeal Life Support (ECLS) and critical care solutions. Headquartered in Shenzhen, China, with an International Office in Mirandola, Italy—the world’s leading medical technology hub—the company combines medical expertise with advanced production capabilities. Its vertically integrated approach ensures full control over manufacturing, from component production to final assembly. Committed to innovation and operational excellence, CBM Lifemotion delivers life-saving solutions worldwide with uncompromising quality and reliability. For more information, visit www.cbmlifemotion.com.
Media Contact
Alice Luppi
Alice.Luppi@CBMsz.com



From Data Overload to Boardroom Clarity: Snowfire AI Launches First Adaptive Decision Intelligence AI Platform, Purpose-Built for Enterprise Executives in the Age of AI
"Snowfire AI is purpose-built for the next generation of enterprise leadership–executives navigating unprecedented volumes of data and the accelerating demands for AI-driven transformation," said Greg Genung, cybersecurity veteran and founder and CEO of Snowfire. "Snowfire elevates the executive function — deploying in under 24 hours to deliver precision intelligence and empower leaders to shape the future, not just react to it."
- Personalized, Tailored AI for Executive Decision Making: Built around each business and executive user profiles, Snowfire AI provides hyper-contextualized adaptive intelligent data processing at scale that produces timely, relevant, and actionable decision intelligence.
- Integrated Business Data, AI Automated Insights at Scale: Connects with nearly 1,000 internal business systems in real-time to turn costly data systems into cross-correlated, synthesized data graphs, identifying timely shifts and critical decisions.
- Synthesized, Real-Time Market-Driven Signals Intelligence: Combines and contextualizes internal data with valuable external market information to deliver military-inspired decision intelligence from relevant news, competitors, suppliers, and trends in real-time.
About Snowfire AI
Snowfire AI redefines executive decision-making through its patent-pending Adaptive Decision Intelligence platform. Synthesizing internal intelligence and external information data, it provides real-time, tailored insights at scale to empower data-driven leadership. Snowfire fosters growth, strengthens margins, and enhances retention by harnessing artificial intelligence to optimize operational efficiency, elevate performance, and deliver strategic outcomes. Headquartered in Austin, Texas, Snowfire pioneers the advancement of data-driven leadership in the age of AI. Available on web, tablet, and mobile for executives on-the-go, Snowfire AI enables cost effective, secure AI transformation in 24 hours or less. For more information about Snowfire AI visit https://www.snowfire.ai or call +1-844-SNO-FIRE to begin a risk-free trial.
Media Contact
Snowfire AI Press
press@snowfire.ai



Celebrating 15 Years of the Global Alliance for Banking on Values (GABV): A Movement for a Better Financial Future
The alliance has not only expanded its reach but has also cemented its role as a thought leader in values-based banking—a model that prioritizes social and environmental impact over short-term profits. The GABV members, ranging from banks to credit unions and microfinance organizations, share a commitment to serving the real economy, strengthening communities, and fostering long-term resilience. As the GABV celebrates this milestone, the organization reflects on its journey, its growing influence, and the impact it continues to drive through advocacy and leadership development.
While CEOs remain the backbone of the movement, the GABV recognizes the importance of engaging practitioners in different areas within its member banks through its communities of practice. There are four key "Communities of Practice" that foster peer learning and cross-sector collaboration. Beyond CEOs and executive leadership, these communities focus on (1) Board Members, (2) Impact Strategy, (3) Marketing & Communications, and (4) Human Development. By serving as a platform for knowledge exchange, the GABV enables its members to scale their impact and remain resilient in a rapidly evolving financial landscape.
About Global Alliance for Banking on Values (GABV)
The Global Alliance for Banking on Values (GABV) is a movement of independent banks with a shared mission to use finance to deliver sustainable economic, social, and environmental development. Founded in 2009, the GABV comprises more than 70 banks and credit unions operating in 45 countries across six continents. Collectively, we serve more than 60 million customers, hold over $250 billion of combined assets under management, and are supported by more than 80,000 coworkers. For more information, visit www.gabv.org.
Media Contact
Sonia Felipe
sonia.felipe@gabv.org
.jpeg)
.jpeg)

This Stress Awareness Month, SABER Highlights the Role of Botanical Science in Managing Chronic Stress
As chronic stress continues to affect millions of Americans—impacting mental health, immune function, and cardiovascular risk—interest in plant-based support has surged. However, the marketplace remains largely unregulated, leaving consumers vulnerable to misleading claims, adulterated products, and synthetic analogs posing as natural remedies.
According to the CDC approximately 14.7% of U.S. adults reported experiencing frequent mental distress, defined as 14 or more mentally unhealthy days in the past 30 days due to stress, depression, or emotional problems.
“Botanicals like kava and kanna show promising effects on GABAergic and serotonergic pathways both of which play a major role in mood regulation and anxiety—however, efficacy depends on responsible use, accurate labeling, and research,” said Dr. Paloma Lehfeldt, plant medicine specialist and medical advisor to SABER. “This Stress Awareness Month, SABER is advocating not only for natural solutions but also for the science and safety standards that must accompany them.”
- Prioritize clinical trials and pharmacologic research into traditional and emerging botanicals.
- Promote continuing medical education (CME) for healthcare providers on safe, evidence-based use of botanicals.
- Support regulatory frameworks that distinguish between natural, well-characterized plant ingredients and synthetic or unapproved analogs.
About Scientific Association for Botanical Education and Research (SABER)
The Scientific Association for Botanical Education and Research (SABER) is a nonprofit organization dedicated to advancing scientific understanding, regulation, and safe access to botanicals. Through research partnerships, policy advocacy, and public education, SABER works to ensure that natural products are studied responsibly, used safely, and regulated appropriately. To learn more, visit www.saberscience.org.
Media Contact
Paloma Lehfeldt
info@saberscience.org

Canadian Athlete Matia Marcantuoni Renews Confidence with Hair Transplant at Istanbul's Hair Center of Turkey
Matia Marcantuoni, a former professional ice hockey player from Canada, had long struggled with gradual hair thinning and a receding hairline—an issue that many men begin facing as early as their late twenties. For Marcantuoni, who spent much of his life in the public eye and under the scrutiny of cameras, the issue was more than superficial. It affected his self-esteem and confidence, especially after retiring from active sports and transitioning to a more visible role in sports media and business.
Turkey’s rise as a hub for cosmetic procedures is no accident. The country combines experienced medical professionals, advanced technology, and competitive pricing, drawing patients from Europe, North America, and the Middle East. The Hair Center of Turkey, in particular, stands out for its focus on personalized care, English-speaking staff, and transparent procedural protocols.
“They didn’t try to sell me anything. They asked about my goals, assessed my donor area in detail via video, and explained the science behind the procedure,” Marcantuoni recalled. “I felt like I was being treated as a person, not a number.”
Istanbul Offers Medical Comfort Beyond Procedure
Upon arriving in Istanbul, Marcantuoni was greeted by a driver arranged by the clinic—a small but thoughtful touch that eased his travel anxieties. He was accommodated in a five-star hotel near the clinic, a standard part of the Hair Center of Turkey’s all-inclusive hair transplant packages.
Recovery and Results: A New Chapter
A Growing Trend
Matia Marcantuoni’s story mirrors the experiences of thousands who have turned to Turkey for hair transplant. With celebrities, athletes, and influencers increasingly sharing their success stories, the stigma around hair transplantation continues to fade, giving rise to a more open dialogue about cosmetic procedures.
The Hair Center of Turkey remains at the forefront of this movement, offering hope and confidence to people from all walks of life. The Hair Center of Turkey treatments are provided by healthcare facilities that possess a health tourism authorization certificate.
About Hair Center of Turkey
Hair Center of Turkey is one of Istanbul’s leading clinics specializing in hair, beard, and eyebrow transplantation. With more than 8,000 patients from over 50 countries, the clinic is known for its advanced techniques such as Sapphire FUE and DHI, internationally certified standards, and personalized care packages that combine medical precision with hospitality.
Dedicated to providing a VIP experience, Hair Center of Turkey ensures patient comfort through services like sedated anesthesia, multilingual support, and comprehensive care packages that include luxury accommodations, airport transfers, and post-operative treatments. The clinic's personalized approach and cutting-edge technology have made it a trusted destination for those seeking natural, lasting hair restoration results.
To learn more or schedule a free consultation, visit haircenterofturkey.com or follow @haircenterofturkey on Instagram.
Media Contact
Necmettin Kar
pr@ajanspr.com.tr
+90 850 304 1728



CHEQ Recognized in Prestigious Cyber 66 List of Hottest Privately Held Cybersecurity Companies
To learn more about CHEQ’s latest capabilities, book a demo here.
About CHEQ
CHEQ is the global leader in go-to-market security. More than 15,000 companies, ranging from emerging brands to the Fortune 50, trust CHEQ to protect business-critical digital interactions from human, agent, and machine-driven threats. Powered by its unrivaled, context-specific detection engine, CHEQ offers the most comprehensive set of solutions for securing go-to-market operations from threats to business continuity, brand reputation, privacy compliance, and marketing effectiveness. It’s why CISOs trust CHEQ, marketers love CHEQ, and more businesses choose CHEQ. Founded in 2016, CHEQ is a global organization with offices in New York, London, Tokyo and Tel Aviv. For more information, visit cheq.ai.
Media Contact
Amy Holtzman
press@cheq.ai



Achieve Natural Beauty with Rhinoplasty: Prof. Dr. Şaban Çelebi’s Expertise Expands to Europe
Rhinoplasty, also known as a nose job, is one of the most transformative cosmetic surgeries available today. It enhances facial harmony, improves breathing, and significantly boosts self-confidence. In Turkey, one name that stands out in this field is Prof. Dr. Şaban Çelebi. With years of experience, an artistic eye, and a deep understanding of facial anatomy, Prof. Dr. Çelebi has helped thousands of patients achieve their ideal nose aesthetics.
Prof. Dr. Şaban Çelebi Launches European Tour to Meet Rhinoplasty Patients – First Stop: Italy in June
European Tour Schedule (2025)
- Italy
- Poland
- United Kingdom
- Spain
- Bulgaria
What Is Rhinoplasty and Who Is It For?
- A hump or bump on the nasal bridge
- A nose that is too large or too small in proportion to the face
- A crooked or asymmetrical nose
- A bulbous, droopy, or upturned nasal tip
- Nasal obstruction or breathing difficulties
Why Choose Prof. Dr. Şaban Çelebi for Rhinoplasty?
Key Advantages of Dr. Çelebi’s Approach:
- Natural-Looking Results: Prof. Dr. Çelebi prioritizes harmony and balance. He avoids the “overdone” look and focuses on maintaining the natural beauty of each face.
- Preservation Rhinoplasty: When possible, he uses techniques that preserve the nasal structure, reducing trauma and speeding up recovery.
- Breathing First: Aesthetic changes are always planned in harmony with functional needs. A beautiful nose that doesn’t breathe well is never the goal.
The Rise of Medical Tourism in Turkey and Dr. Çelebi’s International Appeal
New Horizons: Dr. Şaban Çelebi to Open an Office in Bulgaria
- Consultations Closer to Home: Patients in Europe will be able to consult with Dr. Çelebi without needing to travel to Turkey.
- Pre- and Post-Op Support: Follow-up appointments, assessments, and post-operative care will become more accessible for local patients.
- Bridge Between East and West: With Bulgaria as a strategic location, Dr. Çelebi aims to make elite-level aesthetic surgery available to more people while maintaining the same standard of care he offers in Istanbul.
What Is the Rhinoplasty Journey Like?
- Initial Consultation: This includes an in-depth facial analysis, discussion of aesthetic goals, and functional evaluation.
- Surgery Day: Performed under general anesthesia, the procedure usually takes 2–3 hours, depending on complexity.
- Recovery: Most patients return to daily activities within 7–10 days. Swelling continues to subside over several months, with final results becoming apparent around 6–12 months.
- Follow-Up: Regular post-op check-ins ensure healing is progressing smoothly. With the new Bulgaria office, follow-ups for regional patients will become even more convenient.
Patient Testimonials and Satisfaction
Looking Ahead: Combining Art and Medicine
About Prof. Dr. Şaban Çelebi
With over 27 years of experience and thousands of satisfied patients, Prof. Dr. Şaban Çelebi is a globally recognized specialist in rhinoplasty and nasal surgery. After serving in various prestigious educational and research hospitals across Istanbul, he earned his associate professorship in 2014 and was appointed as a full professor in 2020. Between 2015 and 2018, he worked at Yeni Yüzyıl University Private Gaziosmanpaşa Hospital and currently provides patient care at his private clinic located in Nişantaşı, Istanbul. Prof. Dr. Çelebi has served on the board of the Istanbul Ear, Nose, Throat, and Head & Neck Surgery Specialists Association since 2018 and, in addition to his clinical practice, continues to contribute to the academic field as a faculty member at Maltepe University Faculty of Medicine. For more information, visit https://drsabancelebi.com.
Media Contact
Şaban Çelebi
info@drsabancelebi.com



The OOO Summit Sets the Stage for NYC’s Most Ambitious Business Event of 2025
- Sahil Bloom: New York Times bestselling author and pioneer of "threads" on Twitter.
- Andrew Yang: Founder of the Forward Party and Venture for America, and former CEO of Manhattan Prep.
- Simran Kaur: Founder of Girls That Invest, a media empire with over 10 million downloads and significant revenue.
- Justin Welsh: Solopreneur who has built a one-person business generating over $2 million in annual revenue with 95% profit margins.
- Nathan Barry: Founder and CEO of Kit (formerly ConvertKit).
- Celine Halioua: Founder and CEO of Loyal, a biotech startup that has raised $125 million to develop drugs aimed at extending the healthy lifespan of dogs.
- Nicole Walters: Former 8-figure corporate exec turned entrepreneur who built a multimillion-dollar business by showing others how to monetize their life experience
- Ankur Nagpal: Founder of Teachable (sold for $250M) and Carry—an all-in-one platform for tax-advantaged accounts, investments and strategy for business owners and high-earning professionals.
- Andrew Yeung: Founder of Fibe, Partner at Next Wave NYC, and contributing writer at Business Insider.
The OOO Summit will also be promoted on the HubSpot Podcast Network to millions of people across "The Hustle Daily," "My First Million," and "The Hustle." Key partners of the summit include The Hustle, Notion, Superpower, Agree.com, Niural, Morpheus Talent Group, Roar Apex, citizenM Hotels, and Otis AI.
Ankur Nagpal is the founder and CEO of Carry, and previously founded the edtech company Teachable, before selling it for $250M.
Andrew Yeung is the founder and CEO of Fibe and an investment partner at Next Wave NYC, an early-stage investment fund based out of New York. He has hosted over 200 events for 40,000+ entrepreneurs, investors, and tech professionals. Business Insider dubbed him "The Gatsby of Silicon Alley,” and he has been featured on Bloomberg, Fast Company, Axios, Morning Brew, and AdAge.
Today, their goal is to build the flagship event for entrepreneurs, founders, and creators.
About Fibe
About Carry
Media Contact
Andrew Yeung
andrew@meetfibe.com



Beyond Mars and Venus: New Insight for Today from Dr. John Gray on Women Road Warriors
His newest book, "Beyond Mars and Venus: Relationship Skills for Today's Complex World," offers a compelling and valuable spin for today. This insightful perspective will be discussed on the Women Road Warriors podcast with hosts Shelley Johnson and Kathy Tuccaro offering men and women fresh new insight on how they need to communicate and relate today. The podcast episode will be available on all major podcast channels.
Women Road Warriors is a multiple award-winning women’s empowerment talk show hosted by Shelley Johnson and Kathy Tuccaro that features trailblazers, experts, and celebrity guests on a variety of topics that empower women. As a vanguard for change, it "powers women on the road to success." The show is humorous, entertaining, educational, and sometimes quirky, with lively banter between Shelley, Kathy, and their guests. Women Road Warriors is ranked in the top 2% of podcasts globally by Listen Notes. FeedSpot has ranked it among the top 10 of the Top 100 Best Women Empowerment Podcasts worldwide. Women Road Warriors was recently named Self-Improvement Podcast of the Year by Corporate LiveWire. Women Road Warriors is available on all the major podcast channels as well as women-road-warriors.captivate.fm.
Dr. John Gray is the author of one of the most well-known and trusted relationship books of all time, "Men Are from Mars, Women Are from Venus." USA Today listed his book as one of the top 10 most influential books of the last quarter century. It was the #1 bestselling book of the decade. Dr. Gray’s books have been translated into approximately 45 languages in more than 100 countries and continue to be bestsellers.
Dr. Gray has written over twenty books, most recently "Beyond Mars and Venus: Relationship Skills for Today's Complex World," helping men and women around the globe better understand and respect their differences in both personal and professional relationships. He has appeared repeatedly on "Oprah," as well as on "The Dr. Oz Show," "Today," "CBS This Morning," "Good Morning America," and others. He has been profiled in Time, Forbes, USA Today, and People. He was also the subject of a three-hour special hosted by Barbara Walters
More information is available at: marsvenus.com.
Media Contact
Shelley Johnson
sjohnson@womenroadwarriors.com



FINOM's "Faxvertising" Campaign Turns Fax Machines Against Bureaucracy
- A nationwide distribution of humorous fax messages to small businesses — each written from the perspective of a weary fax machine begging to be retired from a life of bureaucracy. Messages included QR codes linking to free trials of FINOM’s digital banking platform.
- A street marketing event in Berlin where fax machines took to the streets to speak out against bureaucracy. In some of the city’s most popular locations, dozens of fax machines appeared on branded pedestals, printing out their personal pleas to be retired — and calling for a switch to smarter solutions like FINOM.
About FINOM
FINOM is a digital financial services platform designed for the unique needs of entrepreneurs and SMEs across Europe, and an official Visa card partner. FINOM offers a comprehensive set of financial tools that enable business owners to quickly open an account and efficiently manage their finances. The platform simplifies online financial management, payments, invoicing, and expense tracking. Dedicated to supporting entrepreneurs’ growth and competitiveness, FINOM provides innovative financial solutions and holds an Electronic Money Institution (EMI) license operational across Europe. Headquartered in the Netherlands, the company has a strong presence with offices throughout Europe. To learn more about FINOM, visit https://finom.co.
Media Contact
Maria Angelova
ma@axxilion.com



Homeowners Test the Market with Unlisted
Unlisted gives homeowners the chance to stay in control and remain private while still connecting with serious buyers. Users can add photos, descriptions, and more and ensure their data is accurately reflected. By updating their profile and creating a free account on Unlisted, owners can gauge real interest, get a feel for the market, and decide if now is the right time.
At the same time, buyers use Unlisted to uncover options they won’t find anywhere else. When there is limited inventory and a competitive market, Unlisted gives buyers a new way to expand their search and reach out to owners directly. It opens up a new world of possibility where connection and curiosity lead the way.
With Unlisted, homeowners can:
- Stay in control: No formal listing, no public pressure
- Gauge interest: See if buyers are out there without committing to a sale
- Stay private: Share only what they choose with interested buyers
- Move at their own pace: Whether they’re planning ahead or testing the waters
In a time when buyers are eager to explore homes not on the market and owners aren’t always ready to list, Unlisted is creating space for a new kind of conversation—quiet, intentional, and driven by real connection.
To claim your home and update your property profile, visit UnlistedHomes.com.
About Unlisted
Unlisted is an AI-powered real estate technology platform designed to reveal off-market property opportunities. By leveraging machine learning, the company creates more dynamic, efficient market opportunities for buyers, sellers, and real estate professionals. For more information, visit https://unlistedhomes.com.
Media Contact
Sophia Jacomet
sophia@unlistedinc.com



The Myth of Nuclear Verdicts: Why Senate Bill 30 Is an Unnecessary Response to Judicial Self-Regulation in Texas
The bill would severely limit what evidence can be presented regarding medical expenses. Currently, injured plaintiffs can present evidence of the full amount billed for their medical care. Under SB30, they would be limited to presenting evidence of the amount actually paid (often reduced rates negotiated by insurance companies) or amounts capped at 300% of Medicare rates—which are typically far below market rates for many services (Hyman & Silver, 2006).
Benson Varghese is the founder and managing partner of Varghese Summersett, a Texas law firm that represents clients in significant wrongful death and injury cases. He is also the creator of Lawft, a law practice management platform built for growth, and the author of Tapped In, a soon-to-be-released book on law firm growth. He can be reached at benson@versustexas.com.
References
- Baker, T. (2005). The medical malpractice myth. University of Chicago Press.
- Behrens, M. A., & Silverman, C. (2017). Nuclear verdicts: Trends, causes, and solutions. IADC Defense Counsel Journal, 84(3), 291-305.
- Black, B., Silver, C., Hyman, D. A., & Sage, W. M. (2005). Stability, not crisis: Medical malpractice claim outcomes in Texas, 1988-2002. Journal of Empirical Legal Studies, 2(2), 207-259.
- Cohen, T. H., & Smith, S. K. (2004). Civil trial cases and verdicts in large counties, 2001. Bureau of Justice Statistics Bulletin, NCJ 202803.
- Finley, L. M. (2004). The hidden victims of tort reform: Women, children, and the elderly. Emory Law Journal, 53, 1263-1314.
- Gregory v. Chohan, 615 S.W.3d 277 (Tex. 2020).
- Hyman, D. A., & Silver, C. (2006). Medical malpractice litigation and tort reform: It's the incentives, stupid. Vanderbilt Law Review, 59(4), 1085-1136.
- Hyman, D. A., Black, B., Silver, C., & Sage, W. M. (2007). Do defendants pay what juries award? Post-verdict haircuts in Texas medical malpractice cases, 1988-2003. Journal of Empirical Legal Studies, 4(1), 3-68.
- Hyman, D. A., Silver, C., Black, B., & Paik, M. (2015). Does tort reform affect physician supply? Evidence from Texas. International Review of Law and Economics, 42, 203-218.
- Paik, M., Black, B., Hyman, D. A., Sage, W. M., & Silver, C. (2012). Will tort reform bend the cost curve? Evidence from Texas. Journal of Empirical Legal Studies, 9(2), 173-216.
- Silver, C., Hyman, D. A., Black, B., & Paik, M. (2008). Does tort reform affect physician supply? Evidence from Texas. Health Affairs, 27(3), 1865-1873.
- Vidmar, N., & Wolfe, M. W. (2009). Punitive damages. Annual Review of Law and Social Science, 5, 179-199.
About Varghese Summersett
Varghese Summersett is a premier personal injury, criminal defense, and family law practice dedicated to helping people through life's greatest challenges. The firm's roster is comprised of experienced, award-winning attorneys committed to providing exceptional legal services. Varghese Summersett has been named a fastest-growing law firm by Inc. 5000. It has also been named a "Best Law Firm," a "DFW Favorite," a "Best Place to Work" and a "Best Places for Working Parents," among numerous other accolades. The firm has locations in Fort Worth, Dallas, Southlake, and Houston, allowing clients throughout Texas to access top-tier legal representation. For more information, visit https://versustexas.com.
Media Contact
Melody Lanier
melody@versustexas.com



Knocknock Launches Mobile App for Realtors and Unveils Global Platform Ambitions
Visit knocknock.me to learn more about how the company’s platform can simplify property management and enhance workflows.
About Knocknock
Knocknock is a real estate technology company committed to transforming the present real estate sector. Knocknock’s long-term vision is to unify real estate interactions within a single, easy-to-use platform — improving transparency, simplifying collaboration, and supporting smarter workflows across the entire industry. The company’s goal is to help everyone in the real estate ecosystem work better together, starting with agents and steadily expanding its reach to more users and use cases. For more information, visit www.knocknock.me.
Media Contact
Support Team
info@knocknock.me
.jpeg)
.jpeg)

Darwin’s Ark Teams Up with Hill’s Pet Nutrition and Leading Research Institutions to Explore Cats’ Genetic Code
- Darwin’s Ark brings its community-powered research platform and strong community connections, which have already catalyzed canine science through its Darwin’s Dogs initiative.
- Hill’s Pet Nutrition brings decades of experience applying genomics research and science-based nutrition to improve the health of companion animals.
- Broad Institute brings cutting-edge technologies and a proven record of accelerating genetic and genomic discoveries through computational biology.
- UMass Chan Medical School brings its research hub that combines medical and comparative genomics expertise to enhance scientific understanding of human diseases.
About Darwin’s Ark
Darwin’s Ark is a community science nonprofit that empowers pet owners to drive large-scale research on dog and cat genetics. By uniting pet lovers with leading scientists, Darwin’s Ark explores the genetic foundations of health and behavior, helping to advance scientific discoveries that improve well-being for both pets and their people. Darwin’s Cats, one of its flagship research initiatives, is the first pet science study to sequence DNA from fur. It’s an easy method that is cat-friendly and will accelerate research to help cats live longer, healthier lives. To learn more, visit https://darwinsark.org.
Founded more than 75 years ago, Hill's Pet Nutrition is committed to providing pets with the best nutrition through extensive research and a scientific understanding of their specific needs. With a team of 220+ veterinarians, PhD nutritionists, and food scientists constantly striving to develop innovative solutions for pet health, Hill's offers a full line of products, including Hill’s Prescription Diet therapeutic nutrition and Hill’s Science Diet wellness products, which are available at veterinary clinics and pet specialty retailers worldwide.
About UMass Chan Medical School
UMass Chan Medical School, one of five campuses of the University of Massachusetts system, comprises the T.H. Chan School of Medicine; the Morningside Graduate School of Biomedical Sciences; the Tan Chingfen Graduate School of Nursing; ForHealth Consulting at UMass Chan Medical School, a public service health care consulting division; MassBiologics, the only nonprofit, FDA-licensed manufacturer of vaccines, biologics and viral vector gene therapies in the United States; and a thriving Nobel-Prize-winning biomedical research enterprise.
UMass Chan Medical School improves the health and wellness of our diverse communities throughout Massachusetts and across the world by leading and innovating in education, research, health care delivery, and public service. UMass Chan has built a reputation as a world-class destination for biomedical research, with more than $300 million in annual funding and more than 500 active clinical trials. It is ranked among the best medical schools in the nation for primary care education and biomedical research by U.S. News & World Report. In 2021, the Medical School received a $175 million gift from The Morningside Foundation and was renamed UMass Chan Medical School. Learn more at www.umassmed.edu.
Media Contact
Hannah Colwell
PR@darwinsark.org



Law Firms Representing More Than 65 Survivors of Sexual Exploitation and Abuse File Lawsuit Against Cedar-Sinai Medical Center and OB-GYN Dr. Barry Brock Alleging Abuse Spanning Decades
The complaint details a disturbing pattern of alleged misconduct dating back to the early 1980s when Dr. Brock began treating patients at Cedars-Sinai Medical Center. According to the legal filing, Dr. Brock’s alleged exploitation and abuse included performing unnecessary and inappropriate vaginal and breast examinations without gloves, making sexually charged comments during examinations, conducting examinations without chaperones present, and other forms of sexual exploitation and abuse which occurred under the guise of providing necessary medical care.
The lawsuit claims that there were numerous red flags and patient complaints regarding Dr. Brock’s conduct over the decades, yet Cedars-Sinai failed to take the necessary action to investigate and protect patients. Instead, the hospital and institutional defendants continued to hold Dr. Brock out to the public and their patients as a trustworthy and competent physician, regularly referring him patients.
The complaint further alleges that when Cedars-Sinai finally suspended Dr. Brock in August 2024, they did so quietly and without notifying current or former patients of the alleged abuse and misconduct surrounding his treatment of patients.
The legal action names multiple defendants, including Cedars-Sinai Medical Center, Cedars Sinai Health System, Cedars-Sinai Medical Group, Cedars-Sinai Women’s Medical Group, Beverly Hills OBGYN, Rodeo Drive Women's Health Center, and Barry J. Brock, M.D., Inc. The complaint outlines 17 causes of action, including gender violence, sexual harassment, sexual assault, sexual battery, unfair business practices, and negligence.
“Institutions like these healthcare providers are responsible for providing a safe and supportive environment for patients. This case reveals a disturbing pattern of institutional failure," said Martin D. Gould, Founding Partner at Stinar Gould Grieco & Hensley. "These women trusted their healthcare providers with their most intimate medical care, only to be exploited and abused. What's perhaps most alarming is the apparent knowledge that Cedars-Sinai and affiliated institutions had about Dr. Brock’s behavior, yet they continued to grant him unfettered access to vulnerable patients for decades.” Michael R. Grieco, Founding Partner of Stinar Gould Grieco & Hensley, added, "The courage of these women coming forward cannot be overstated. Our investigation suggests there may be hundreds, if not thousands, of other victims who have not yet realized that what they experienced wasn't legitimate medical care but sexual abuse. We're committed to holding both Dr. Brock and the institutions that enabled him accountable for the profound harm caused to our clients."
“We applaud the courage of these women who were brave enough to speak out about their experiences in the hope of ending sexual abuse under the guise of medical care at Cedars-Sinai and elsewhere. We are thoroughly investigating these claims to bring to light what occurred here and, hopefully, secure some form of justice for the victims,” said Sam Dordulian, Founding Partner of Dordulian Law Group.
The lawsuit seeks compensatory and punitive damages for the plaintiffs and calls for court ordered supervision of the defendant institutions to prevent similar situations in the future. The case is filed in the Superior Court of the State of California, County of Los Angeles, Central District. The survivors are represented by Martin D. Gould, Michael R. Grieco, and Valerie Letko from Stinar Gould Grieco & Hensley, and Sam Dordulian of Dordulian Law Group.
If you are a former patient of Dr. Brock who believes you experienced unnecessary invasive medical exams and abuse, or have any helpful information, please contact Stinar Gould Grieco & Hensley, PLLC by emailing justice@sgghlaw.com or visiting www.sgghlaw.com to discuss your legal rights.
About Stinar Gould Grieco & Hensley, PLLC
Dordulian Law Group (DLG) is a top-rated California sexual abuse firm that has helped countless survivors secure justice. Founded by Sam Dordulian, a former Los Angeles County Deputy District Attorney and sex crimes prosecutor, DLG offers a unique brand of compassionate and all-encompassing legal representation for survivors. Our Sexual Assault Division features proven attorneys, victim advocates, a licensed clinical therapist/mental health specialist, and a retired LAPD sex crimes detective. Attorney Sam Dordulian’s more than 25 years of legal experience includes over 100 jury trial victories. To date, DLG has helped clients obtain more than $200,000,000.00 in settlements and verdicts while maintaining a 98% win record. For more information, visit www.dlawgroup.com.
Media Contact
Lynn Smith
lynn@lynnsmithtv.com

GWM Unveils Its Global Strategy at Auto Shanghai 2025: From China’s GWM to a Global Brand
GWM implements a "Global Standards + Local Customization" strategy. With a global vision, GWM consistently adheres to international standards to ensure quality and safety. The company has earned multiple five-star ratings in rigorous testing programs, fulfilling its commitment to unified global safety benchmarks. As President Mu stated at the launch event, “There is always room to raise the bar for safety. There is no such thing as ‘just right’—only the relentless pursuit of better.”
In 1990, Jack Wey, at the age of 26, took over a small manufacturing plant in Baoding. By 1995, GWM had entered the market with the successful launch of the “Deer” pickup and began expanding internationally in 1997. Today, GWM POER has become the No. 1 pickup brand in China and ranks among the top three globally. In 2002, GWM shifted its focus to SUVs, with models like the Safe and HAVAL H6 achieving strong sales, marking its transformation from "China’s SUV leader" to a "Global Family Mobility Partner." Since 2016, GWM has established multiple brands to penetrate the high-end and niche markets. WEY opened the door to the premium segment, ORA captured the personalized new energy market, and TANK emerged as a new force in global hardcore off-roading, setting new standards to meet the diverse needs of users worldwide.
GWM’s globalization approach is deeply rooted in "being in the local market, for the local market, and integrating into the local community."
About GWM
GWM is a global intelligent technology company, whose business includes automobile and parts design, R&D, production, sales and service. Our brands include HAVAL, WEY, ORA, TANK and GWM Pickup. To learn more, visit www.gwm-global.com.
Media Contact
Carol Wang
globalmarketing@gwm.cn



Enterprise Web Dev IT Monks Levels Up with WordPress VIP Silver Partnership
WordPress Development Excellence
Advanced Enterprise Solutions with a Client-First Focus
- Full compliance with ADA and WCAG accessibility standards
- System integration with leading platforms like SAP, Oracle, Salesforce, HubSpot, and Zoho CRM
- Advanced security, including multi-factor authentication and frameworks like CIS Controls, ISO/IEC 27001, and NIST
- Data migration, cloud optimization, disaster recovery, and consolidation
- Enterprise hosting via WordPress VIP’s high-performance, scalable infrastructure
- Marketing automation, leveraging tools like Salesforce Marketing Cloud and Google Analytics 360
- Ongoing maintenance, security patching, performance tuning, and cyber threat protection
About IT Monks
IT Monks is a leading enterprise WordPress development agency focused on building custom websites that blend innovative design with powerful performance. Our client-first philosophy ensures tailored digital solutions that fuel measurable business growth. For more information, visit https://itmonks.com.
Media Contact
Alex Osmichenko
alex@itmonks.com
+1 646-941-7882
.jpeg)
.jpeg)

Quill & Arrow LLP: Advocating for California Consumers in Lemon Law and Personal Injury Cases
How Did the Firm Manage to Recover the Money?
- $375,000 settlement for a client dealing with recurring engine problems on a vehicle valued at $125,000.
- $320,000 settlement for a client facing transmission and engine problems in a car valued at $107,000.
- $250,000 settlement for a client with electrical problems in a car valued at $83,000.
Making Lemon Law Accessible to All
Endnote
About Quill & Arrow LLP
Quill & Arrow LLP is a California-based litigation firm specializing in personal injury and Lemon Law disputes. Founded with the intention of providing personalized legal representation, the firm emphasizes close collaboration with clients to thoroughly investigate claims and maximize potential recovery. Their aggressive litigation strategy includes a willingness to take cases to trial when necessary, aiming to secure favorable outcomes for their clients. To learn more, visit https://www.quillarrowlaw.com.
Media Contact
Kristina Grodz
kristina@quillarrowlaw.com
.jpeg)
.jpeg)

Lipella Reports Positive Results from Second Cohort in LP-310 Phase 2a Trial for Oral Lichen Planus
The 0.50 mg cohort was treated over a four-week period, with Week 4 serving as the primary endpoint. Week 6 data reflect follow-up assessments two weeks after the end of treatment.
Treatment with LP-310 at the 0.50 mg dose demonstrated statistically significant improvements across key clinical endpoints, including reductions in inflammation and ulceration, decreased symptom severity and pain, and improved global response scores.
The formulation was well tolerated, with no treatment-related serious adverse events and no study discontinuations. Pharmacokinetic analysis confirmed minimal systemic absorption of tacrolimus, supporting its targeted, local delivery.
The study is now fully enrolled across all three planned dose cohorts. Final results from the 1.0 mg cohort are expected in Q2 2025 and are intended to support multiple development milestones, including:
- Finalizing Phase 2a clinical dataset
- Advancing regulatory discussions
- Preparing for Phase 2b IND submission in late 2025
- Pursuing FDA Breakthrough Therapy designation
Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on developing new drugs by reformulating active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella targets diseases with significant unmet needs, where no approved drug therapies currently exist. The company completed its initial public offering in 2022. Learn more at lipella.com and follow us on X and LinkedIn.
This press release includes certain "forward-looking statements" which are not historical facts, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included in this press release regarding, among other things, our strategy, future operations, financial position, prospects, clinical trials, regulatory approvals, pipeline and opportunities, sources of growth, successful implementation of our proprietary technology, plans and objectives are forward-looking statements. Forward-looking statements can be identified by words such as "may," "will," "could," "continue," "would," "should," "potential," "target," "goal," "anticipates," "intends," "plans," "seeks," "believes," "estimates," "predicts," "expects," "projects" and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding future events and financial trends that we believe may affect among other things, market and other conditions, our financial condition, results of operations, business strategy, short- and long-term business operations and objectives, and financial needs. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. There are risks, uncertainties and other factors, both known and unknown, that could cause actual results to differ materially from those in the forward-looking statements which include, but are not limited to, the current clinical trial results for LP-310 and our other products general capital market risks, our ability to regain and maintain compliance with the listing standards of The Nasdaq Stock Market LLC, regional, national or global political, economic, business, competitive, market and regulatory conditions, our current liquidity position and the need to obtain additional financing to support ongoing operations, and other risks as more fully described in our filings with the U.S. Securities and Exchange Commission. Any forward-looking statement made by us is based upon the reasonable judgment of our management at the time such statement is made and speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. In addition, the information contained in this press release is as of the date hereof, and the Company has no obligation to update such information, including in the event that such information becomes inaccurate. You should not construe the contents of this press release as legal, tax or investment advice and should consult with your own advisors as to the matters described herein, as applicable.
Media Contact
Jeff Ramson
jramson@pcgadvisory.com



Texas Senate Bill 30: An Existential Threat to Justice Based on a Fictional “Nuclear Verdict” Crisis According to Two Prominent Attorneys
An op-ed by leading attorneys Cody Dishon and Will Moye provides insights into why Texas Senate Bill 30 is an existential threat to justice based on a fictional “nuclear verdict” crisis.
During Texas' current legislative session, the insurance lobby is targeting key pillars of justice: the Texas Constitution, our court system, the right to a fair jury trial, and long-established rule of law.
Two identical bills—House Bill 4806 and Senate Bill 30 (“SB 30”)—have been filed in Austin. If passed, the new law will dramatically increase insurance company profits to the detriment of everyday Texans. These proposals would also strip away protections from people killed or severely injured on Texas roads, refinery workers burned and maimed in explosions, sexual assault survivors, and families who have lost someone in tragic accidents.
Proponents of the bill, primarily the notorious Texans for Lawsuit Reform (“TLR”), which has funneled millions and millions of dollars to influence Texas politicians for decades, recently confessed under oath that general liability and commercial automobile policy premiums will not decrease with the passage of SB 30. [1] Nevertheless, TLR continues to support SB 30, driven by corporate greed.
While CEOs at these insurance companies are making over $20 million a year [2] and operating with record-breaking billion-dollar profits, [3] TLR has introduced no bill addressing insurance reform. There are no bills to cap the excessive salaries of wealthy executives, but TLR made sure to cap damages for victims of sexual assault, injured children, and other catastrophic hurt Texans. No bill to hold accountable the bad companies who prioritize profits over safety. No bill to tackle bad faith insurance practices that drive up litigation costs and harm Texas families.
Instead of focusing on insurance reform, holding unsafe companies accountable, or addressing bad faith insurance practices, TLR concentrates on making it difficult for innocent victims of tragic circumstances to seek justice. Indeed, TLR’s latest bills are designed to close the courthouse doors to some of the most vulnerable citizens in Texas.
To justify the elimination of Texans’ rights and attack on our court system, the insurance lobby has embraced the new marketing buzzword “nuclear verdict.” However, upon closer evaluation, this marketing pitch provides no justification for undermining Texans’ fundamental rights. The Texas Legislature faces a choice: to protect people or to protect insurance companies.
The Elimination of Rights and Burdens of Recovery for Families
Seeking sweeping and unprecedented change, SB 30 aims to functionally eliminate damages for victims and families. Traditional elements of damages for mental anguish, physical impairment, [4] disfigurement, [5] loss of companionship, and loss of consortium would be gutted under SB 30.[6] Most of these human damages [7] have been part of Texas law for over a century.
These are not just abstract legal concepts. These are real injuries, real families, and real lives that SB 30 would devastate.
Real Stories, Real Harm
The Senate Committee heard powerful testimony from a corporate attorney and mother who spoke out against the bill. [8] Her five-year-old child suffered severe burns to half of his face, neck, chest, and arms due to a defective product. After multiple surgeries and skin grafts, he was left with permanent disfigurement—yet under SB 30, her child would be left with nothing, despite a long-standing history of allowing the jury discretion in awarding disfigurement damages under Texas law.
Moreover, sexual assault victims had to share their most emotionally and physically traumatic stories in front of the Senate Committee and the public. It was impactful, brave, and courageous. But why must sexual assault victims share these horrible events with the Senate? These victims deserve full justice against the wrongdoers and do not owe an explanation to the Senate or TLR. Under current Texas law, sexual assault victims can recover damages. Perhaps this alone illustrates the absolute insanity surrounding the controversial SB 30 bill being proposed.
Forcing sexual assault victims to relive and recount their personal trauma in front of the public, just to ensure their current rights are protected against an insurance-friendly bill, is cruel and violates human decency. As stated by Charla Aldous, a prominent attorney who testified on behalf of her clients, “[f]or many of our clients, the emotional, physical, and mental toll of sexual assault is already unbearable. Senate Bill 30 threatens to worsen their suffering by shielding corporate wrongdoers from accountability.” [9]
Loss of Family Bonds
SB 30 would similarly eliminate the jury’s discretion in awarding damages for loss of consortium and loss of companionship and society, which are those damages awarded to families who lose the love, support, and closeness of a parent, spouse, or child due to wrongful death or serious injury. The Senate heard heartbreaking stories from grieving families who emphasized the irreparable impact of such losses. These damages, recognized by the Texas Supreme Court time and time again, [10] are now subject to crushing limitations that, in practice, will eliminate them.
The Fiction of the “Nuclear Verdict” Crisis
To disregard Texans’ fundamental rights and eliminate their recovery, TLR uses the alarming term "nuclear verdicts." This is precisely how the insurance industry wants it to sound. They coined the phrase and spread it widely across the legal and media landscape, shaping public perception to believe that Texas is facing a wave of massive, unpreventable jury awards. What supporters of SB 30 hope Texans won’t realize is that, despite costly marketing campaigns by international insurance companies aimed at increasing profits, these so-called nuclear verdicts are actually extremely rare.
An objective analysis of Texas jury verdicts between 2021 and 2025 reveals that only 4.6% of all verdicts exceeded $10 million. [11] It is unclear how many of these included actual damages for essential needs such as future medical care and lost earnings. Nearly half (48.4%) of all verdicts were less than $50,000. Motor vehicle accident cases made up 74.2% of all trials, with a median award of a mere $38,600. In fact, roughly 66% of all tried cases resulted in either a defense verdict or an award of less than $50,000.
TLR is desperately attempting to take away Texans’ constitutional rights by claiming juries are getting it wrong. But as the actual evidence shows—not just rhetoric and anecdotal stories from TLR—juries are typically accurate and remain the best arbiters of factual disputes between parties.
The Honorable Mike Engelhart, recipient of the 2024 Trial Judge of the Year Award from the Texas Association of Civil Trial and Appellate Specialists, [12] testified in opposition to SB 30. Drawing on his 16 years on the bench, he reminded lawmakers that juries are essential part of the judicial system and generally reach the correct result. [13] The former judge also confirmed that his extensive judicial experience aligns with the data: “nuclear verdicts” are extremely rare, and appellate courts already serve as an effective backstop for verdicts unsupported by evidence. Notably, no testimony or evidence presented to the Senate Committee cited even a single appellate case upholding a nuclear verdict that lacked sufficient evidentiary support.
It is time for TLR to respect our Constitution, our juries, and our judges.
More Fiction: The Insurance Premium Crisis
Another reason we know the so-called “nuclear verdict” crisis is merely a marketing tactic for profit is that insurance companies are thriving. AM Best, a credit rating agency focused on the insurance industry, recently revised its 2024 profit figures upward by $25 billion, bringing the total to $169 billion. You read that right. Big insurance companies made $169 billion in profits last year. That is a 90% increase from 2023 and a 333% increase from 2022! The idea that there is an insurance crisis driving the need for significant tort reform is pure fiction, manufactured by industry lobbyists.
Despite making billions in profits and paying executives millions each year, insurance companies refuse to lower premiums for consumers. As one analysis put it, “Insurance companies are very fond of increasing their policyholders’ premiums and then crafting an explanation for the hikes that fits their interests, even if it doesn’t fit the data.” [14]
Insurance companies and TLR love blaming judges, juries, and lawyers for ‘social inflation.’ But the ‘social inflation’ argument is without merit. As detailed in Unpacking the Insurance Industry’s “Social Inflation” Lie, “[w]hen we look at the data, the theorized “social inflation” does not exist and claims payouts by insurers are not skyrocketing. Instead, insurance companies are hyping up this assertion as an excuse to price-gouge businesses and consumers.” [15]
Can TLR please focus on meaningful insurance reform, particularly addressing price gouging, instead of targeting sexual assault victims, victims of catastrophic injuries, or grieving families who have lost a loved one due to corporate negligence?
The bottom line is that SB 30’s passage will not lower rates at all. Lee Parsley, a lobbyist from TLR who testified in favor of SB 30, made this point crystal clear during a hearing before the Committee on Judiciary & Civil Jurisprudence regarding a separate trucking tort reform bill aimed at limiting liability for companies that break the law and endanger lives. He stated: “I will not tell you today that this bill will lower insurance rates. I won’t do it, and the insurance industry probably won’t either, because we don’t know that.” [16]
Harder and More Expensive for Texans to Receive Healthcare Due to Unconstitutional Caps
There is more to the new controversial law. SB 30 wants to cap past and future medical expenses in violation of the Texas Constitution. [17] The purpose behind this part of the bill is to make it harder and more expensive for families to receive medical treatment after being injured by others. SB 30 further limits patient access to care and forces families, healthcare providers, and the public to cover medical bills that exceed either an arbitrary and incomplete database or restricted Medicare rates.
If you or a loved one are slammed into by a reckless driver and transported from the scene by ambulance through no choice of your own, and the ambulance charges exceed the arbitrary caps set by SB 30, you will be responsible for those charges with no recourse against the at-fault party. This is just one of countless examples of the real-world impact SB 30 will have on Texans.
According to the Texas Medical Association, “Texas is the uninsured capital of the United States. More than 4.3 million Texans—including 623,000 children—lack health insurance.” [18] If you do not have health insurance, the Texas Legislature wants to cap your recoverable medical bills in a lawsuit. This deters, if not eliminates, healthcare providers from treating the most vulnerable Texans and shifts the financial burden to families or the public through Medicare, Medicaid, or other government assistant programs. Meanwhile, the party responsible for causing the injuries avoids accountability and passes the costs onto victims and taxpayers.
It is important to remember that Texans are only seeking medical care because a company or another wrongdoer harmed them.
One misleading and frankly silly narrative repeated throughout the Senate Testimony was the claim that healthcare providers can charge whatever they want and that there is little to nothing the defense bar can do, leaving juries clueless. [19] That claim does not reflect litigation practices or reality. In almost every case, big or small, the defense bar routinely hires medical billing experts to evaluate and challenge the reasonableness of medical charges. The jury hears testimony from both the defense’s billing expert and the healthcare providers regarding billing before reaching a decision. It is the jury, not the Senate or TLR, that decides whether those charges are fair and reasonable.
Additionally, SB 30 mandates that a victim’s lawyer create a two-year spreadsheet of payments to healthcare providers. Beyond the undue burden, unnecessary expenses, HIPPA violations, and accounting challenges this imposes, SB 30 does not require the defense bar to maintain a two-year record of all payments to their preferred experts. The purpose is to stack the deck against victims and the lawyers that try to help them.
A Massive Giveaway to Insurance Companies
People from all walks of life have spoken out against the controversial SB 30, including a former trial court judge with 16 years of experience, medical doctors and other healthcare professionals, sexual assault survivors, conservatives, defense lawyers, and families who lost loved one’s due to corporate negligence.
There is no doubt that these changes overwhelmingly favor big insurance companies and corporations at the expense of people. If SB 30 becomes law, many sexual assault and injury victims will be left without the financial support they need to cover medical expenses, lost wages, and long-term care. Failure to hold the responsible companies accountable will result in the public picking up the costs, as sexual assault victims and families devastated after a tragic event generally do not have the financial resources to cover such losses.
If passed, SB 30 would give sweeping legal immunity to insurance companies and negligent parties by stripping away critical rights from all Texans. It would gut nearly a century of established law, deny fair compensation to victims, and tilt the scales of justice in favor of corporations over communities.
This is not reform—it’s an injustice. And it flies in the face of the rule of law.
Authors
Cody Dishon is a board-certified personal injury trial lawyer who became a lawyer to help people and make a difference in their lives. He is a strong advocate of the Seventh Amendment right to a jury trial, firmly believing that people in the community should be deciding disputes.
Will Moye is an ABOTA-admitted trial lawyer who spent twenty-five years defending clients at trial for insurance companies including defending the high exposure and “nuclear verdict” type of cases. He left that side in March of 2024, to open a Plaintiff’s litigation boutique firm.
Notes
[1] See https://house.texas.gov/videos/21687 (starting at 6:20:35 - 6:21:40) (emphasis added).
[2] See e.g., “As Insurance Rates Skyrocket, Executives Pull in Millions,” Consumer Federation of America. https://consumerfed.org/press_release/as-insurance-rates-skyrocket-executives-pull-in-millions/.
[3] See e.g., “The Insurance Industry is Quietly Making Record Profits,” American Association for Justice (AAJ), accessed on April 1, 2025. https://www.justice.org/resources/research/insurance-industry-is-quietly-making-record-profits.
[4] Physical impairment damages, for example, have been commonly recognized in Texas courts since the early 1930s. They exist to compensate people who can no longer walk, lift, drive, or care for themselves due to their injuries. In its Golden Eagle decision, the Texas Supreme Court reaffirmed the importance of these damages being separate from mental anguish and even referenced a 1933 opinion to underscore their historical and legal significance. Golden Eagle Archery, Inc. v. Jackson, 116 S.W.3d 757, 766-772 (Tex. 2003) (citing Dr. Pepper Bottling Co. v. Rainboldt, 66 S.W.2d 496, 501 (Tex. Civ. App.—Waco 1933), rev'd on other grounds, Schroeder v. Rainboldt, 128 Tex. 269, 97 S.W.2d 679 (Tex. 1936) (physical impairment were properly awarded to a young girl who was struck by a delivery truck and could no longer have children due to permanent bladder injury caused by the crash—clearly an impairment worth compensating) (emphasis added). In fact, all of the human damages are separate from mental anguish, but TLR pushes for them to either be eliminated or improperly conflated with other damages. That violates a century of Texas case law.
[5] Disfigurement is different than physical impairment and mental anguish. See e.g., Hous. Transit Co. v. Felder, 146 Tex. 428, 433, 208 S.W.2d 880, 883 (1948). For example, disfigurement damages specifically address the permanent scarring on a five-year-old child’s face—it has nothing to do with mental anguish damages like TLR suggests. See infra.
[6] That is because SB 30 fails to properly categorize these human damages as required by well-established Texas Supreme Court precedent. Additionally, SB 30 attempts to narrowly define human damages based on a selective and incorrect interpretation of legal precedent. The initial version of SB 30 and current House Bill 4806 sought to outright eliminate physical impairment, disfigurement, loss of consortium, and loss of companionship.
[7] Human damages include physical pain, mental anguish, physical impairment, disfigurement, loss of companionship, and loss of consortium. Each of these damages are separate and have distinct meaning under the law.
[8] See https://senate.texas.gov/videoplayer.php?vid=21561&lang=en (starting at 2:53:28).
[9] See Aldous, C. (2025, April) Discussing her testimony before the Senate on the bill in question. LinkedIn: https://www.linkedin.com/posts/charlaaldous_on-monday-i-testified-before-the-texas-senate-activity-7313728913979936770-S3ez/; see also https://senate.texas.gov/videoplayer.php?vid=21561&lang=en (starting at 2:01:17).
[10] See e.g., Estate of Clifton v. S. Pac. Transp. Co., 709 S.W.2d 636 (Tex. 1986).
[11] Data compiled from LexisNexis Verdict & Settlement Analyzer reports.
[12] “UHLC alumnus Mike Engelhart ’95 wins 2024 Trial Judge of the Year Award,” University of Houston Law Center. https://www.law.uh.edu/alumni/Featured-Alumni/2024-0514Engelhart.asp
[13] See https://senate.texas.gov/videoplayer.php?vid=21561&lang=en (5:11:35 through 5:55:12).
[14] DeLong, Michael. “Unpacking the Insurance Industry’s “Social Inflation” Lie. Consumer Federation of America. https://consumerfed.org/unpacking-the-insurance-industrys-social-inflation-lie/ (emphasis added).
[15] Id. (emphasis added).
[16] See https://house.texas.gov/videos/21687 (starting at 6:21:06 – 6:21:16) (emphasis added).
[17] TLR seeks to cap victims’ recoveries, but why not also cap insurance executives’ salaries?
[18] See e.g., https://www.texmed.org/uninsured_in_texas/ (emphasis added).
[19] Other misleading narratives suggest that defendants cannot obtain the plaintiff’s medical history before trial, particularly regarding pre-existing conditions. These narratives are falsehoods. It would constitute reversible error for any trial court to deny defendants access to the plaintiff’s prior medical history concerning relevant pre-existing conditions.
About Ferguson Law Firm
The Ferguson Law Firm, LLP was established in Beaumont, TX, by personal injury attorney Paul “Chip” Ferguson, Jr. to advocate for clients that have suffered injuries due to negligence of another person or party. Distinguished Senior Partner Mrs. Jane Swearingen Leger joined the firm in 2016. Mrs. Leger brings her many years of service to the firm, with expertise in industrial accidents, employment discrimination law, and personal injury. Jane has successfully argued before the Fifth Circuit Court of Appeals and the Texas Supreme Court.
Mr. Ferguson is the 18-wheeler attorney for people injured in trucking accidents. In addition to being named “Lawyer of the Year” on multiple occasions, Mr. Ferguson has received many other honors, including being named Litigation Star by Benchmark Litigation Induction, inducted as an Advocate into the American Board of Trial Advocates, and named to the Texas Top 100 by the National Trial Lawyers Association, and named to National Top 10 by the National Academy of Trial Attorneys.
Both attorneys have been duly recognized for their exceptional work and have received numerous honors and accolades in their field. Our firm is dedicated, and we aim to seek the justice that our clients deserve.
At 30 years old, ownership partner Cody Dishon achieved one of the most significant milestones in his career—becoming one of the youngest attorneys in Texas history to achieve his Board Certification in Personal Injury Trial Law from the Texas Board of Legal Specialization. This specialization requires one to obtain at least 10 jury verdicts in personal injury cases as lead trial counsel. With less than 2% of all lawyers in Texas holding this objective title, his achievement stands as a testament to his dedication, knowledge, work ethic, and expertise.
For more information, visit https://www.thefergusonlawfirm.com.
Disclaimer
In some jurisdictions, this press release may be considered attorney advertising.
Media Contact
Amanda Orr
amanda@orrstrategygroup.com




Turn your news into performance
EZ Newswire is the only news platform connecting the most influential organizations with the most trusted media outlets.